Effect of IL-10 on formation of foam cell induced by ox-LDL

Glass C K, Witztum J L. Atherosclerosis. the road ahead. Cell, 2001, 104(4): 503–516

Hansson G K. Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol, 2001, 21(12): 1876–1890

Frostegard J. Autoimmunity, oxidized LDL and cardiovascular disease. Autoimmun Rev, 2002, 1(4): 223–237

Fichtlscherer S, Breuer S, Heeschen C, Dimmeler S, Zeiher A M. Interleukin-10 serum Levels and systemic Endothelial vasoreactivity in patients with coronary artery disease. J Am Coll Cardiol, 2004, 44(1): 44–49

Anguera I, Miranda-Guardiola F, Bosch X, Filella X, Sitges M, Marín J L, Betriu A, Sanz G. Elevation of serum levels of the anti-inflammatory cytokine interleukin-10 and decreased risk of coronary events in patients with unstable angina. Am Heart J, 2002, 144(5): 811–817

Heesche C, Dimmeler S, Hamm C W, Fichtlscherer S, Boersma E, Simoons M, Zeiher A. Serum level of the anti-inflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation, 2003, 107(16): 2109–2114

Von Der Thusen J H, Kuiper J, Fekkes M L, Vos P D, Van Berkel T J C and Biessen E A L. Attenuation of atherogenesis by systemic and local adenovirus-mediated gene transfer of interleukin-10 in LDLr-/-mice. FASEB J, 2001, 15(14): 2730–3732

Pinderski L J, Fischbein M P, Subbanagounder G, Fishbein M C, Kubo N, Cheroutre H, Curtiss L K, Berliner J A, Boisvert W A. Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient mice by altering lymphocyte and macrophage phenotypes. Circ Res, 2002, 90(10): 1064–1071

Rubic T, Lorenz R L. Downregulated CD36 and ox-LDL uptake and stimulated ABCA1/G1 and cholesterol efflux as anti-atherosclerotic mechanisms of interleukin-10. Cardiovasc Res, 2006, 69(2): 527–535

Zerbinatti C, Gore R W. Uptake of modified low-density lipoproteins alters actin distribution and locomotor forces in macrophages. Am J Physiol Cell Physiol, 2003, 284(2): 555–561

Murphy J E, Tedbury P R, Homer-Vanniasinkam S, Warlker J, Ponnambalam S. Biochemistry and cell biology of mammalian scavenger receptors. Atherosclerosis, 2005, 182(1): 1–15

Ohashi R, Mu H, Yao Q, Chen C. Atherosclerosis: immunopathogenesis and immunotherapy. Med Sci Monit, 2004, 10(11): RA255–RA260

Greaves D, Gordon S. Recent insights into the biology of macrophage scavenger receptors. J lipid Res, 2005, 46(1): 11–20

Lucas A D, Greaves D R. Atherosclerosis: role of chemokines and macrophages. Expert Rev Mol Med, 2001, 3(25): 1–18

Mostafa Mtairag E, Chollet-Martin S, Oudghiri M, Laquay N, Jacob M P, Michel J B, Feldman L J. Effects of interleukin-10 on monocyte/endothelial cell adhesion and MMP-9/TIMP-1 secretion. Cardiovas Res, 2001, 49(4): 882–890

Potteaux S, Esposito B, van Oostrom O, Brun V, Ardouin P, Groux H, Tedgui A, Mallat Z. Leukocyte-Derived Interleukin 10 Is Required for Protection Against Atherosclerosis in Low-Density Lipoprotein Receptor Knockout Mice. Arterioscler Thromb Vasc Biol, 2004, 24(8): 1474–1478

Raychaudhuri B, Fisher C J, Farver C F, Malur A, Drazba J, Kavuru M S, Thomassen M J. Interleukin 10 (IL-10)-mediated inhibition of inflammatory cytokine production by human alveolar macrophages. Cytokine, 2000, 12(9): 1348–1355

Shanley T P, Vasi N, Denenberg A. Regulation of chemokine expression by IL-10 in lung inflammation. Cytokine, 2000, 12(7): 1054–1064

Amico G D, Frascaroli G, Bianchi G, Transidico P, Doni A, Vecchi A, Sozzani S, Allavena P, Mantovani A. Uncoupling of inflammatory chemokine receptors by IL-10: generation of functional decoys. Nature Immunology, 2000, 1(5): 387–391

Peiser L, Winther M, Makepeace K, Hollinshead M, Coull P, Plested J, Kodama T, Moxon E, Gordon S. The class A macrophage scavenger receptor is a major pattern recognition receptor for nesseria meningititdis which is independent of lipopolysaccharide and not required for secretory responses. Infect Immun, 2002, 70(10): 5346–5354

van Berkel T, Out R, Hoekstra M, Kuiper J, Biessen E, van Eck M. Scavenger receptors: friend or foe in atherosclerosis. Curr Opin Lipidol, 2005, 16(5): 525–535

Mallat Z, Besnard S, Duriez M, Deeluze V, Emmanuel F Bureau MF, Soubrier F, Esposito B, Duez H, Fievet C, Staels B, Duverger N, Scherman D, Tedgui A. Protective role of IL-10 in atherosclerosis. Circ Res, 1999, 85(8): e 17–24